Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/50563
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Torres, Fernando | en_US |
dc.contributor.author | Quintana, Jose | en_US |
dc.contributor.author | Díaz, Jesús G. | en_US |
dc.contributor.author | Carmona, Armando J. | en_US |
dc.contributor.author | Estévez, Francisco | en_US |
dc.contributor.other | Diaz, Jesus | - |
dc.contributor.other | Quintana, Jose | - |
dc.contributor.other | Estevez, Francisco | - |
dc.contributor.other | Torres Andon, Fernando | - |
dc.date.accessioned | 2018-11-24T17:01:31Z | - |
dc.date.available | 2018-11-24T17:01:31Z | - |
dc.date.issued | 2008 | en_US |
dc.identifier.issn | 1360-8185 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/50563 | - |
dc.description.abstract | In the present study we demonstrated that the flavonoid derivative trifolin acetate (TA), obtained by acetylation of naturally occurring trifolin, induces apoptosis. Associated downstream signaling events were also investigated. TA-induced cell death was prevented by the non-specific caspase inhibitor z-VAD-fmk and reduced by the presence of the selective caspase inhibitors z-LEHD-fmk (caspase-9), z-DEVD-fmk (caspase-3) and z-VEID-fmk (caspase-6). The apoptotic effect of TA was associated with (i) the release of cytochrome c from mitochondria which was not accompanied by dissipation of the mitochondrial membrane potential (Delta Psi(m)), (ii) the activation of the mitogen-activated protein kinases (MAPKs) pathway and (iii) abrogated by the over-expression of Bcl-2 or Bcl-x(L). TA-induced cell death was attenuated by inhibition of extracellular signal-regulated kinases (ERK) 1/2 with U0126 and inhibition of p38(MAPK) with SB203580. In contrast, inhibition of c-Jun NH2-terminal kinase (JNK) by SP600125 significantly enhanced apoptosis. Although reactive oxygen species (ROS) increased in response to TA, this did not seem to play a pivotal role in the apoptotic process since different anti-oxidants were unable to provide cell protection. The present study demonstrates that TA-induced cell death is mediated by an intrinsic-dependent apoptotic event involving mitochondria and MAPK, and through a mechanism independent of ROS generation. | en_US |
dc.language | eng | en_US |
dc.relation | Nuevos Compuestos Antileucémicos | en_US |
dc.relation.ispartof | Apoptosis : an international journal on programmed cell death | en_US |
dc.source | Apoptosis[ISSN 1360-8185],v. 13, p. 716-728 | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 3209 Farmacología | en_US |
dc.subject.other | N-Terminal-Kinase | en_US |
dc.subject.other | Jun Nh2-Terminal Kinase | en_US |
dc.subject.other | Protein-Kinase | en_US |
dc.subject.other | Induced Apoptosis | en_US |
dc.subject.other | Cytochrome-C | en_US |
dc.subject.other | Poly(Adp-Ribose) Polymerase | en_US |
dc.subject.other | Mediated Apoptosis | en_US |
dc.subject.other | Signaling Pathways | en_US |
dc.subject.other | Carcinoma Cells | en_US |
dc.subject.other | Cycle Arrest | en_US |
dc.title | Trifolin acetate-induced cell death in human leukemia cells is dependent on caspase-6 and activates the MAPK pathway | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1007/s10495-008-0202-0 | en_US |
dc.identifier.scopus | 42149184054 | - |
dc.identifier.isi | 000255030400011 | - |
dcterms.isPartOf | Apoptosis | - |
dcterms.source | Apoptosis[ISSN 1360-8185],v. 13 (5), p. 716-728 | - |
dc.contributor.authorscopusid | 55366045300 | - |
dc.contributor.authorscopusid | 8681043500 | - |
dc.contributor.authorscopusid | 7401604406 | - |
dc.contributor.authorscopusid | 23968598700 | - |
dc.contributor.authorscopusid | 7003810011 | - |
dc.description.lastpage | 728 | en_US |
dc.description.firstpage | 716 | en_US |
dc.relation.volume | 13 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.identifier.wos | WOS:000255030400011 | - |
dc.contributor.daisngid | 34941095 | - |
dc.contributor.daisngid | 2952604 | - |
dc.contributor.daisngid | 128315 | - |
dc.contributor.daisngid | 356785 | - |
dc.contributor.daisngid | 4617455 | - |
dc.contributor.daisngid | 384944 | - |
dc.identifier.investigatorRID | L-6099-2014 | - |
dc.identifier.investigatorRID | K-5709-2014 | - |
dc.identifier.investigatorRID | K-5125-2014 | - |
dc.identifier.investigatorRID | D-5184-2009 | - |
dc.description.numberofpages | 13 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:Torres, F | - |
dc.contributor.wosstandard | WOS:Quintana, J | - |
dc.contributor.wosstandard | WOS:Diaz, JG | - |
dc.contributor.wosstandard | WOS:Carmona, AJ | - |
dc.contributor.wosstandard | WOS:Estevez, F | - |
dc.date.coverdate | Mayo 2008 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.jcr | 3,971 | - |
dc.description.jcrq | Q2 | - |
dc.description.scie | SCIE | - |
item.fulltext | Sin texto completo | - |
item.grantfulltext | none | - |
crisitem.project.principalinvestigator | Estévez Rosas, Francisco Jesús | - |
crisitem.author.dept | GIR IUIBS: Bioquímica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología | - |
crisitem.author.dept | GIR IUIBS: Bioquímica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología | - |
crisitem.author.orcid | 0000-0001-8225-4538 | - |
crisitem.author.orcid | 0000-0002-9728-2774 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Quintana Aguiar, José Martín | - |
crisitem.author.fullName | Estévez Rosas, Francisco Jesús | - |
Appears in Collections: | Artículos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.